ALPHARETTA, Ga., June 1, 2018 /PRNewswire/ -- Halyard Health,
Inc. (NYSE: HYH) a market-leading medical devices company,
today announced the business' rebrand to Avanos Medical, Inc.
("Avanos"). Avanos' vision is to be the best at getting patients
back to the things that matter. Derived from the words "advanced"
and "innovation," the new name and brand emphasize the company's
focus on innovating with speed to deliver better, more sustainable
patient outcomes.
Avanos provides pioneering pain management and chronic care
therapies and solutions, with a relentless focus on advancing
change in the medical devices industry to address unmet medical
needs and improve patients' quality of life.
"Having completed the divestiture of S&IP, Avanos is now a
pure-play medical devices company," said Joe Woody, Avanos chief executive officer.
"Today, Avanos is positioned with a forward-thinking mindset and
the firepower to make strategic investments in breakthrough
innovation and acquisitions in attractive markets."
"Our new name and brand align with our streamlined operational
approach and our commitment to delivering the very best for
patients," Woody continued. "I am excited to work with our talented
team to establish Avanos as a market leader in the industry for
years to come."
The change in name from Halyard to Avanos will be effective
June 30, 2018. In connection
with this rebrand, the company's stock ticker symbol will change
from "HYH" to "AVNS" on the New York Stock Exchange. The first day
of trading under the new ticker symbol will be July 2, 2018.
About Halyard Health
Halyard Health (NYSE: HYH) is a medical technology company focused
on delivering clinically superior breakthrough medical device
solutions to improve patients' quality of life. Headquartered
in Alpharetta, Georgia, Halyard is
committed to addressing some of today's most important healthcare
needs, such as reducing the use of opioids while helping patients
move from surgery to recovery. Halyard develops, manufactures and
markets its recognized brands in more than 90 countries. For more
information, visit www.halyardhealth.com.
Forward-Looking Statements
This press release contains information that includes or is based
on "forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements are based on the current plans and expectations of
management and are subject to various risks and uncertainties that
could cause our actual results to differ materially from those
expressed or implied in such statements. Forward-looking statements
include all statements that do not relate solely to historical or
current facts, and can generally be identified by the use of words
such as "may", "believe", "will", "expect", "project", " estimate",
"anticipate", "plan", or "continue" and similar expressions,
among others. Factors that may cause actual results to differ
materially from the anticipated results expressed in such forward
looking statements include, but are not limited to: weakening of
economic conditions that could adversely affect the level of demand
for our products; pricing pressures generally, including
cost-containment measures that could adversely affect the price of
or demand for our products; changes in foreign exchange markets;
legislative and regulatory actions; unanticipated issues arising in
connection with clinical studies and otherwise that affect U.S.
Food and Drug Administration approval of new products; changes in
reimbursement levels from third-party payors; a significant
increase in product liability claims; the impact of investigative
and legal proceedings and compliance risks; the impact of the
federal legislation to reform the United
States healthcare system; changes in financial markets; and
changes in the competitive environment. Additional information
concerning these and other factors that may impact future results
is contained in our filings with the U.S. Securities and Exchange
Commission, including our most recent Form 10-K and Quarterly
Reports on Form 10-Q.
View original
content:http://www.prnewswire.com/news-releases/halyard-health-announces-corporate-rebranding-changes-name-to-avanos-medical-inc-300657895.html
SOURCE Halyard Health, Inc.